Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiazhuo Wu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
BMC Medicine|July 13, 2023
PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphomaJiazhuo Wu, Cunzhen Shi, Hongwen Li, et al.
Cancer Medicine|April 11, 2023
A second-generation CD38-CAR-T cell for the treatment of multiple myelomaHongwen Li, Jing Li, Jiazhuo Wu, et al.
Cell Death & Disease|August 20, 2024
LMP1 enhances aerobic glycolysis in natural killer/T cell lymphomaWenting Song, Yuyang Gao, Jiazhuo Wu, et al.
Annals of Hematology|July 27, 2023
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphomaChen Gong, Jiazhuo Wu, Wenting Song, et al.
BMC Medicine|August 30, 2023
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphomaHongwen Li, Wenting Song, Jiazhuo Wu, et al.
Hematological Oncology|May 19, 2025
MerTK is Ectopically Expressed and Affects the Biological Function in Diffuse Large B-Cell LymphomaYan Li, Cunzhen Shi, Jiazhuo Wu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
BMC Medicine|July 13, 2023
PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphomaJiazhuo Wu, Cunzhen Shi, Hongwen Li, et al.
Cancer Medicine|April 11, 2023
A second-generation CD38-CAR-T cell for the treatment of multiple myelomaHongwen Li, Jing Li, Jiazhuo Wu, et al.
Cell Death & Disease|August 20, 2024
LMP1 enhances aerobic glycolysis in natural killer/T cell lymphomaWenting Song, Yuyang Gao, Jiazhuo Wu, et al.
Annals of Hematology|July 27, 2023
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphomaChen Gong, Jiazhuo Wu, Wenting Song, et al.
BMC Medicine|August 30, 2023
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphomaHongwen Li, Wenting Song, Jiazhuo Wu, et al.
Hematological Oncology|May 19, 2025
MerTK is Ectopically Expressed and Affects the Biological Function in Diffuse Large B-Cell LymphomaYan Li, Cunzhen Shi, Jiazhuo Wu, et al.
Pageof 1